CoChat

Distinct expression patterns of the transcription factor E2F‐1 in relation to tumour growth parameters in common human carcinomas

Zacharatos, Panayotis, Kotsinas, Athanassios, Evangelou, Konstantinos, Karakaidos, Panagiotis, Vassiliou, Leandros‐V, Rezaei, Nousin, Kyroudi, Aspasia, Kittas, Christos, Patsouris, Eystratios, Papavassiliou, Athanasios G, Gorgoulis, Vassilis G · 2004 · The Journal of Pathology
Cited by 83

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

E2F‐1 is a pivotal transcription factor that integrates signals from a variety of G1/S phase regulators and modulates diverse cellular functions, such as DNA synthesis, repair, mitosis, and apoptosis. Its role in cellular proliferation and apoptosis, as depicted from experimental models and limited reports in human malignancies, remains a matter of debate. Recently, in non‐small cell lung cancer, it was observed that E2F‐1 overexpression was associated with tumour growth, implying an ‘oncogenic’ effect. To clarify further the role of E2F‐1 in carcinogenesis, the investigation was expanded in four of the most common human malignancies by examining its expression status and putative impact on tumour kinetics. These issues were addressed by immunohistochemical and molecular means in 52 breast carcinomas, 42 prostate adenocarcinomas, 58 colon adenocarcinomas, and 77 superficial bladder transitional cell carcinomas (TCCs). The following results were found: (i) in breast carcinomas, E2F‐1 expression correlated with proliferation (p < 0.001) and growth index (p = 0.001); (ii) in prostate adenocarcinomas, absence of E2F‐1 was noted, in contrast to its expression in normal and hyperplastic glands; (iii) in colon adenocarcinomas, E2F‐1 expression was inversely related to growth index (p = 0.001), being expressed in lesions with increased apoptosis (p = 0.001) and low proliferation (p < 0.001); and (iv) in superficial TCCs, E2F‐1 expression correlated with proliferation (p = 0.002). Taken together, these results suggest that E2F‐1 has a growth‐promoting effect in breast carcinomas and superficial TCC, whereas the opposite seems to be the case for colon and prostate cancer. To interpret the above findings, the status of the pRb and p53 tumour suppressor pathways, which are known to affect E2F‐1 activity, was further investigated. The results suggest that the actions of E2F‐1 are mainly dependent on the functionality of these pathways. Nevertheless, the data also imply that p53‐independent pathways may play a nodal role in the function of E2F‐1 in colon cancer. Copyright © 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/path.1582

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 83

Metadata

Authors
Zacharatos, P., Kotsinas, A., Evangelou, K., Karakaidos, P., Vassiliou, L., Rezaei, N., Kyroudi, A., Kittas, C., Patsouris, E., Papavassiliou, A. G., & Gorgoulis, V. G.
Venue
The Journal of Pathology
Publisher
Wiley
Published
2004-06-21
Volume
203
Issue
3
Pages
744-753
ISSN
  • 0022-3417 (ISSN-L)
  • 1096-9896
OpenAlex
W2003414599
Cited by
83
References
2
FWCI
2.64
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.